Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|April 1, 2005
The intermolecular Pauson-Khand reactionSusan E Gibson, Nello MainolfiACS Medicinal Chemistry Letters|April 21, 2016
Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and RedesignNello Mainolfi, Rajeshri Karki, Fang Liu, et al.Drug Discovery Today. Technologies|June 16, 2019
Targeted protein degradation mechanismsYi Zhang, Christine Loh, Jesse Chen, et al.Organic Letters|December 15, 2010
Continuous flow coupling and decarboxylation reactions promoted by copper tubingYun Zhang, Timothy F Jamison, Sejal Patel, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 16, 2004
A new class of non-racemic chiral macrocycles: a conformational and synthetic studySusan E Gibson, Nello Mainolfi, S Barret Kalindjian, et al.ACS Medicinal Chemistry Letters|April 21, 2016
Core Replacements in a Potent Series of VEGFR-2 Inhibitors and Their Impact on Potency, Solubility, and hERGNello Mainolfi, James Powers, Erik Meredith, et al.Journal of Medicinal Chemistry|June 7, 2013
An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonistNello Mainolfi, James Powers, Jakal Amin, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphomaGregory S Ducker, Jonathan M Ghergurovich, Nello Mainolfi, et al.Cell Metabolism|February 19, 2019
Serine Metabolism Supports Macrophage IL-1β ProductionArianne E Rodriguez, Gregory S Ducker, Leah K Billingham, et al.Nature Communications|June 23, 2026
Structural basis for selective and potent degradation of IRAK4 by KT-474Xue Fei, Anand Ramanathan, Caroline A Daigle, et al.Pageof 3